Nitredon (Nitrazepam)

Nitrazepam, the active ingredient in Nitredon, is a benzodiazepine presented as a tablet for oral use. It acts on the central nervous system to produce a calming effect and is commonly prescribed for short‑term management of insomnia, various anxiety disorders, and as a pre‑operative sedative in adult patients.

GNH USA supplies Nitredon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, globally ensuring consistent product quality through rigorous quality‑assurance procedures and adherence to EU regulatory standards.

Nitrazepam is a benzodiazepine that modulates the GABA‑A receptor pathway, providing therapeutic effects in several central nervous system conditions. - Insomnia: helps initiate and maintain sleep, reducing nighttime awakenings. - Anxiety disorders: alleviates excessive worry and tension, promoting calmness. - Preoperative sedation: provides calming and amnesic effects before surgical procedures.

Nitrazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness during daytime. - Dizziness: light‑headed sensation or loss of balance. - Fatigue: reduced energy and increased tiredness. - Impaired coordination: clumsiness or difficulty with fine motor tasks. - Memory disturbances: short‑term recall problems. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Paradoxical agitation: increased anxiety, aggression, or hostility. - Dependence and withdrawal: physical or psychological reliance with abrupt discontinuation. - Mood changes: depression or suicidal thoughts. - Hepatic dysfunction: abnormal liver enzymes or jaundice.

When prescribing Nitrazepam, clinicians should consider several safety precautions to minimise risk. - Assess medical history: evaluate for respiratory disorders, hepatic impairment, or glaucoma. - Avoid abrupt discontinuation: taper dose gradually to prevent withdrawal symptoms. - Use caution with CNS depressants: limit concurrent alcohol, opioids, or other sedatives. - Monitor elderly patients: increased sensitivity may lead to falls or confusion. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Nitrazepam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression. - Barbiturates: additive CNS depression can increase sedation and risk of overdose. - Antifungal azoles (e.g., ketoconazole): may raise nitrazepam plasma levels, enhancing toxicity. - Macrolide antibiotics (e.g., erythromycin): can inhibit metabolism, leading to accumulation. - CNS depressants (e.g., antihistamines, muscle relaxants): heightened sedative effects.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase risk of serotonin syndrome or enhanced sedation. - Anticonvulsants (phenytoin, carbamazepine): may reduce nitrazepam effectiveness. - Herbal supplements (St. John’s wort): may induce metabolism, lowering drug concentration. - Diuretics: may exacerbate electrolyte imbalances, affecting CNS stability. - Caffeine: can counteract sedative effect, requiring dose adjustment.